The Health Technology Assessment (HTA), Value & Evidence (HV&E) team is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions to inform healthcare decision-making. The Director, HTA, Value & Evidence (HV&E) – Obesity will support the strategic goals of the Primary Care Division by driving optimal patient access for Pfizer’s portfolio of Obesity products. This role influences global business objectives by guiding strategic evidence development to ensure optimal patient access for Obesity treatments. The HV&E Director will be responsible for developing and executing against the global evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables. This position will be part of Pfizer’s dynamic Global HTA Value and Evidence team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to Obesity treatments. This position will be working closely with the Primary Care Global Access Strategy and Pricing (GASP) team, US Market Access team, cross-functional and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and society in general.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director